Clinical Trials Directory

Trials / Completed

CompletedNCT05701137

Effectiveness of an EMDR Intervention for Perinatal Loss

Effectiveness of an Eye Movement Desensitization and Reprocessing (EMDR) Intervention for the Prevention of Post-traumatic Symptoms in Perinatal Loss

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators objectives is to assess the effectiveness of Eye Movement Desensitization and Reprocessing - recent traumatic episode (EMDR-RTE) as a preventive intervention for Posttraumatic Stress Disorder (PTSD) symptoms after perinatal loss. The hypothesis is that EMDR-RTE treatment may prevent post-traumatic and depressive symptoms in women who suffered perinatal loss.

Detailed description

Perinatal loss is a general term that refers to a loss from conception to one month postpartum. It is a grief that is still socially unauthorized, however, it is a situation with significant traumatic potential. However, there are no studies evaluating the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) for the prevention or treatment of perinatal loss. We propose an one-site, open label, randomized controlled trial with the aim of assessing the effectiveness of EMDR recent traumatic episode (EMDR-RTE) as a preventive intervention for PTSD symptoms after perinatal loss. A total of 40 women who have suffered a perinatal loss from the Maternal-Fetal Medicine Service of a tertiary university hospital will be recruited. Women will be randomized to EMDR-RTE or treatment as usual (TAU). Researchers will compare EMDR-RTE and TAU to see if women receiving EMDR-RTE treatment had lower levels of post-traumatic and depressive symptoms.

Conditions

Interventions

TypeNameDescription
OTHEREMDR-RTEThe experimental group will have EMDR recent traumatic event.
OTHERTAUThe comparator group will have usual psychological intervention.

Timeline

Start date
2023-04-17
Primary completion
2024-11-30
Completion
2025-03-23
First posted
2023-01-27
Last updated
2025-07-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05701137. Inclusion in this directory is not an endorsement.